Drug Shortage Report for MAR-VALACYCLOVIR
| Report ID | 48026 |
| Drug Identification Number | 02441586 |
| Brand name | MAR-VALACYCLOVIR |
| Common or Proper name | MAR-Valacyclovir |
| Company Name | MARCAN PHARMACEUTICALS INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | VALACYCLOVIR |
| Strength(s) | 500MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 Tablet |
| ATC code | J05AB |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2018-05-02 |
| Actual start date | 2018-05-02 |
| Estimated end date | Unknown |
| Actual end date | 2018-05-02 |
| Shortage status | Resolved |
| Updated date | 2021-10-26 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2021-10-26 | French | Compare |
| v6 | 2021-10-26 | English | Compare |
| v5 | 2018-07-05 | French | Compare |
| v4 | 2018-07-05 | English | Compare |
| v3 | 2018-05-03 | English | Compare |
| v2 | 2018-05-02 | French | Compare |
| v1 | 2018-05-02 | English | Compare |
Showing 1 to 7 of 7